CVS Health (NYSE:CVS – Get Free Report) had its price target boosted by Leerink Partners from $51.00 to $55.00 in a report released on Tuesday. The firm presently has a “market perform” rating on the pharmacy operator’s stock. Leerink Partners’ price objective would indicate a potential downside of 13.02% from the company’s previous close.
A number of other equities analysts have also weighed in on CVS. TD Cowen upped their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Evercore ISI upped their price objective on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Monday, January 27th. Barclays decreased their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. UBS Group dropped their price target on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Truist Financial decreased their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $67.78.
Check Out Our Latest Stock Report on CVS Health
CVS Health Stock Up 15.0 %
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, sell-side analysts predict that CVS Health will post 5.14 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CVS. State Street Corp lifted its stake in CVS Health by 3.6% in the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock valued at $3,554,475,000 after purchasing an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of CVS Health by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator’s stock valued at $1,211,582,000 after buying an additional 689,867 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock worth $880,319,000 after acquiring an additional 6,475,271 shares during the period. Norges Bank purchased a new stake in CVS Health in the 4th quarter worth about $839,574,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in CVS Health by 5.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 12,918,949 shares of the pharmacy operator’s stock valued at $579,932,000 after purchasing an additional 710,281 shares during the last quarter. 80.66% of the stock is owned by institutional investors.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- How to Use the MarketBeat Dividend Calculator
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Short Nasdaq: An Easy-to-Follow Guide
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.